Cargando…
The many NOs to the use of Class IC antiarrhythmics: weren’t the guidelines too strict?
Class IC antiarrhythmic drugs (AADs) currently represent a cornerstone in the therapy of atrial fibrillation, both for the restoration of sinus rhythm and for the prophylaxis of long-term relapses. They also play an important role in the treatment of idiopathic ventricular arrhythmias. Following the...
Autores principales: | Turturiello, Dario, Cappato, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653146/ https://www.ncbi.nlm.nih.gov/pubmed/36380776 http://dx.doi.org/10.1093/eurheartjsupp/suac073 |
Ejemplares similares
-
How much does the presentation pattern of atrial fibrillation affect thrombo-embolic risk and mortality?
por: Turturiello, Dario, et al.
Publicado: (2023) -
Scotland could eliminate the coronavirus – if it weren't for England
por: Marshall, Michael
Publicado: (2020) -
Polygenic risk score and age: an extra help in the cardiovascular prevention of the young?
por: Temporelli, Pier Luigi
Publicado: (2022) -
Surgical approach to combined mitral and tricuspid valve disease: good neighbourhood rules
por: Ascione, Guido, et al.
Publicado: (2022) -
Is it possible that angioplasty does not improve the quality of life in patients with stable angina?
por: Golino, Paolo
Publicado: (2022)